These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 8877776)

  • 1. Beneficial effects of angiotensin I converting enzyme inhibitor on post-ischemic contractile function of perfused rat heart.
    Tanonaka K; Kamiyama T; Takezono A; Sakai K; Takeo S
    J Mol Cell Cardiol; 1996 Aug; 28(8):1659-70. PubMed ID: 8877776
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beneficial effects of quinidine on post-ischemic contractile failure of isolated rat hearts.
    Liu JX; Tanonaka K; Sanbe A; Yamamoto K; Takeo S
    J Mol Cell Cardiol; 1993 Oct; 25(10):1249-63. PubMed ID: 8263956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improvement of ischemia/reperfusion-induced contractile dysfunction of perfused hearts by class Ic antiarrhythmic agents.
    Liu JX; Tanonaka K; Ohtsuka Y; Sakai Y; Takeo S
    J Pharmacol Exp Ther; 1993 Sep; 266(3):1247-54. PubMed ID: 8371134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective effects of the potent Na/H exchange inhibitor methylisobutyl amiloride against post-ischemic contractile dysfunction in rat and guinea-pig hearts.
    Moffat MP; Karmazyn M
    J Mol Cell Cardiol; 1993 Aug; 25(8):959-71. PubMed ID: 8263964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preservation of mitochondrial function during ischemia as a possible mechanism for cardioprotection of diltiazem against ischemia/reperfusion injury.
    Takeo S; Tanonaka K; Iwai T; Motegi K; Hirota Y
    Biochem Pharmacol; 2004 Feb; 67(3):565-74. PubMed ID: 15037208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Local inhibition of bradykinin degradation in ischemic hearts.
    Linz W; Martorana PA; Schölkens BA
    J Cardiovasc Pharmacol; 1990; 15 Suppl 6():S99-109. PubMed ID: 1697370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dichotomy in the post-ischemic metabolic and functional recovery profiles of isolated blood-versus buffer-perfused heart.
    Galiñanes M; Bernocchi P; Argano V; Cargnoni A; Ferrari R; Hearse DJ
    J Mol Cell Cardiol; 1996 Mar; 28(3):531-9. PubMed ID: 9011636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exogenous adenosine, supplied transiently during reperfusion, ameliorates depressed endogenous adenosine production in the post-ischemic rat heart.
    Smolenski RT; Simmonds HA; Chambers DJ
    J Mol Cell Cardiol; 1997 Jan; 29(1):333-46. PubMed ID: 9040048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective modulation of endogenous nitric oxide formation in ischemia/reperfusion injury in isolated rat hearts--effects on regional myocardial flow and enzyme release.
    Han H; Kaiser R; Hu K; Laser M; Ertl G; Bauersachs J
    Basic Res Cardiol; 2003 May; 98(3):165-74. PubMed ID: 12883834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of aprindine on ischemia/reperfusion-induced cardiac contractile dysfunction of perfused rat heart.
    Kamiyama T; Tanonaka K; Hayashi J; Takeo S
    Jpn J Pharmacol; 1996 Mar; 70(3):227-34. PubMed ID: 8935716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic and functional protection by selective inhibition of nitric oxide synthase 2 during ischemia-reperfusion in isolated perfused hearts.
    Ramasamy R; Hwang YC; Liu Y; Son NH; Ma N; Parkinson J; Sciacca R; Albala A; Edwards N; Szabolcs MJ; Cannon PJ
    Circulation; 2004 Apr; 109(13):1668-73. PubMed ID: 15051645
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protection against ischemia/reperfusion injury and myocardial dysfunction by antisense-oligodeoxynucleotide directed at angiotensin-converting enzyme mRNA.
    Chen H; Mohuczy D; Li D; Kimura B; Phillips MI; Mehta P; Mehta JL
    Gene Ther; 2001 May; 8(10):804-10. PubMed ID: 11420645
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardioprotection: intermittent ventricular fibrillation and rapid pacing can induce preconditioning in the blood-perfused rat heart.
    Hearse DJ; Ferrari R; Sutherland FJ
    J Mol Cell Cardiol; 1999 Nov; 31(11):1961-73. PubMed ID: 10591023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of landiolol on mechanical and metabolic changes in rat reperfused ischaemic hearts.
    Sakanashi M; Sakanashi M; Sugahara K; Sakanashi M
    Clin Exp Pharmacol Physiol; 2007; 34(1-2):55-60. PubMed ID: 17201736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Post-ischemic contractile dysfunction does not correlate with an elevated intracellular free [Mg2+]: a 31P-NMR study on isolated rat and rabbit hearts.
    Schreur JH; de Beer R; Van Echteld CJ; Ruigrok TJ
    J Mol Cell Cardiol; 1993 Sep; 25(9):1015-24. PubMed ID: 8283465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Global ischemic duration and reperfusion function in the isolated perfused rat heart.
    Palmer BS; Hadziahmetovic M; Veci T; Angelos MG
    Resuscitation; 2004 Jul; 62(1):97-106. PubMed ID: 15246589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The dual effects of nitric oxide synthase inhibitors on ischemia-reperfusion injury in rat hearts.
    Kobara M; Tatsumi T; Takeda M; Mano A; Yamanaka S; Shiraishi J; Keira N; Matoba S; Asayama J; Nakagawa M
    Basic Res Cardiol; 2003 Sep; 98(5):319-28. PubMed ID: 12955405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential beneficial as well as detrimental effects of chronic treatment with lisinopril and (or) spironolactone on isolated hearts following low-flow ischemia in normal and infarcted rats.
    Rochetaing A; Chapon C; Marescaux L; Le Bouil A; Furber A; Kreher P
    Can J Physiol Pharmacol; 2003 Sep; 81(9):864-72. PubMed ID: 14614522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiac-specific effects of parathyroid hormone-related peptide: modification by aging and hypertension.
    Ross G; Schlüter KD
    Cardiovasc Res; 2005 May; 66(2):334-44. PubMed ID: 15820202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison between ranolazine and CVT-4325, a novel inhibitor of fatty acid oxidation, on cardiac metabolism and left ventricular function in rat isolated perfused heart during ischemia and reperfusion.
    Wang P; Fraser H; Lloyd SG; McVeigh JJ; Belardinelli L; Chatham JC
    J Pharmacol Exp Ther; 2007 Apr; 321(1):213-20. PubMed ID: 17202401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.